Isofol Medical AB (FRA:5IU) Ending Cash Position : €11.35 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Isofol Medical AB Ending Cash Position?

Isofol Medical AB's Ending Cash Position for the quarter that ended in Mar. 2024 was €11.35 Mil.

Isofol Medical AB's quarterly Ending Cash Position increased from Sep. 2023 (€12.19 Mil) to Dec. 2023 (€12.35 Mil) but then declined from Dec. 2023 (€12.35 Mil) to Mar. 2024 (€11.35 Mil).

Isofol Medical AB's annual Ending Cash Position declined from Dec. 2021 (€36.95 Mil) to Dec. 2022 (€17.33 Mil) and declined from Dec. 2022 (€17.33 Mil) to Dec. 2023 (€12.35 Mil).

Isofol Medical AB Ending Cash Position Historical Data

The historical data trend for Isofol Medical AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Isofol Medical AB Ending Cash Position Chart

Isofol Medical AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

12.12

11.44

36.95

17.33

12.35

Isofol Medical AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															14.61	13.44	12.19	12.35	11.35

Isofol Medical AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Isofol Medical AB's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	17.034	+	-4.684
	=	12.35

Isofol Medical AB's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	12.207	+	-0.853
	=	11.35

Isofol Medical AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Isofol Medical AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Isofol Medical AB (FRA:5IU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Isofol Medical AB (FRA:5IU) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

ISOFOL:Sweden

Address

Arvid Wallgrens Backe 20, Biotech Center, Gothenburg, SWE, SE-413 46

Website

http://www.isofol.se

Isofol Medical AB is a pharmaceutical company. It is a manufacturer of folate-based therapies. The company's drug candidate Modufolin enhances the effect of the current chemotherapy treatment for patients treated for colorectal cancer. Its products are used to increase efficacy and reduce the side effects of antimetabolite cancer treatment.

Isofol Medical AB (FRA:5IU) Headlines

No Headlines